Biogen Gets Win In Drug IP Fight As Judge Overrides Jury
A New Jersey federal judge on Friday overrode a jury's verdict and instead found that EMD Serono Inc. and Pfizer Inc. infringed Biogen MA Inc.'s valid patent for the multiple sclerosis...To view the full article, register now.
Already a subscriber? Click here to view full article